AzTrials
AzTrials

Carpal Tunnel SyndromePhase 2NCT03476486

A Pilot Study to Evaluate the Effectiveness of Ultrasound Guided Looped Thread Carpal Tunnel Release

A Phase 2 study testing Thread carpal tunnel release in people with Carpal Tunnel Syndrome, run by University of Alberta.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Carpal tunnel syndrome occurs when a nerve gets pinched as it passes through a confined tunnel within the wrist and hand. It is the most commonly pinched nerve and often results in disabling hand numbness, tingling, pain and weakness. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Carpal Tunnel Syndrome
What is being tested?
Thread carpal tunnel release
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
No sites listed yet
Study dates
20 May 2016to 20 Jan 2018
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • >18 years of age
  • symptoms (hand numbness, tingling, weakness or pain; symptom aggravation with repetitive or sustained gripping; nocturnal symptom exacerbation) and signs (hand sensory disturbance or weakness; positive median nerve Tinel's sign or Phalen's test) compatible with carpal tunnel syndrome
  • symptom duration >3 months refractory to conservative treatment (i.e. wrist splints, activity modification, NSAID, +/- intracarpal tunnel corticosteroid injection)
  • nerve conduction study abnormalities compatible with moderate to severe median neuropathy at the carpal tunnel (motor and sensory conduction slowing across the carpal tunnel +/- evidence of axonal loss)
  • signed informed consent

Who cannot join

  • ultrasound identifies a bifid median nerve or persistent median artery at the carpal tunnel inlet
  • Clinical or electrophysiologic evidence of a neurologic disorder of the upper extremity besides carpal tunnel syndrome (i.e. proximal median neuropathy; ulnar or radial neuropathy, brachial plexopathy, cervical radiculopathy or generalized polyneuropathy)
  • Inability to understand the informed consent or the Boston Carpal Tunnel Questionnaire
  • Coagulopathy or anticoagulation that cannot be stopped for the carpal tunnel release procedure
  • Local anesthetic allergy
  • systemic infection or a local infection at the procedure site

About this study

Carpal tunnel syndrome occurs when a nerve gets pinched as it passes through a confined tunnel within the wrist and hand. It is the most commonly pinched nerve and often results in disabling hand numbness, tingling, pain and weakness. For moderate and severe cases, an operation is often performed that cuts the ligament that presses on the nerve. This surgery is generally very successful but involves a 2-5 cm long incision at the base of the palm. Recovery from the surgery usually takes 3-8 weeks. Ultrasound provides a clear noninvasive way of looking at the contents of the carpal tunnel. A technique has been developed whereby a wire thread is looped around the ligament using a needle guided by ultrasound. The ligament is cut by the wire below the surface of the skin. This technique results in 2 needle puncture holes instead of the open incision of the traditional surgery. The investigators have completed research on this technique in cadavers. It was confirmed that complete or almost complete cutting of the ligament can be safely and predictably accomplished. This research will look at the effectiveness of this looped thread technique of carpal tunnel release on patients who have carpal tunnel syndrome. Specifically, participants will be required to: 1. rate the severity of their carpal tunnel syndrome symptoms and disability using a standard questionnaire, 2. measure hand sensation, 3. measure pinch and grip strength tests of their hands, 4. undergo ultrasound measurements of the size of the pinched nerve at the carpal tunnel, and 5. undergo electrical tests to measure the nerves ability to conduct impulses across the carpal tunnel. These will be measured before the looped wire procedure and at 3 and 6 months following the procedure. Recovery time will also be measured.

Read the detailed description

Objectives: to evaluate the effectiveness and safety of a minimally invasive ultrasound-guided looped thread technique of carpal tunnel release

Background: Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy, having a prevalence of 3.7%. CTS is the 2nd leading worktime loss condition. Open surgical decompression of the carpal tunnel is an evidence-based and commonly performed treatment for moderate to severe cases, predictably providing long-term symptom relief. This surgical technique involves placing a 2-5 cm long longitudinal incision at the palm, incising the skin, subcutaneous tissue, palmar fascia, palmaris longus tendon (if present) and transverse carpal ligament under direct visualization. After 3-8 weeks of recovery, most patients experience excellent relief of symptoms and improvement in hand function. On occasion, the procedure is complicated by nerve damage, scar or pillar pain. A variety of strategies have been devised to minimize the invasive nature of carpal tunnel release in hopes to reduce post procedure pain, weakness and recovery time. In the late 1980s, an endoscopic release technique was devised. A recent meta-analysis of existing randomized control trials comparing open to endoscopic release found endoscopic release to provide better early recovery of grip and pinch strength, less scar tenderness and earlier returned to work (~9 days). There was a similar risk of pillar pain and reoperation, and a higher risk of nerve injury (mostly transient neurapraxia). The development of high-resolution ultrasound scanning allows detailed visualization of the carpal tunnel and its contents. Hydrodissection, the injection of fluid during ultrasound visualization, adds to image clarity of both the contents of the carpal tunnel as well as the location of operative instruments. A few minimally invasive ultrasound-guided percutaneous carpal tunnel release techniques have been described. The cutting instruments have included needle tip, knife, saws blades, and thread. Initial results of these techniques suggest that they are feasible, safe, effective and are associated with short recovery times. The most recently described minimally invasive technique involves percutaneously looping a cutting thread around the transverse carpal ligament using a needle under ultrasound guidance. By reciprocally sliding the 2 ends of the thread back and forth like a Gigli saw, the transverse carpal ligament is transected. Only 2 needle puncture site are required. The looped thread carpal tunnel release (TCTR) procedure was initially performed on a single cadaveric hand and dissection demonstrated complete transection of the transverse carpal ligament and no injury to other structures. The authors then performed the same procedure on 34 hands of 20 patients. The primary outcome measure was the Levine-Katz questionnaire completed 3 months postprocedure. The questionnaire scores were compared to those reported in the literature for open and endoscopic release techniques and were found to be similar. No post TCTR complications were reported. Our research group has recently completed a cadaveric evaluation of this technique and found that ultrasound accurately defines the critical boundries and contents of the carpal tunnel in all cases, complete or near-complete transection of the transverse carpal ligament was achieved and no trauma was sustained by any structure within the carpal tunnel other than the transverse carpal ligament.

Procedure/Methods: subjects with clinical and electrophysiologically confirmed CTS from the practice of the principal investigator will be invited to participate. The 1st phase of this study will involve TCTR of 5 carpal tunnels. Within a month prior to and at 3 and 6 months post procedure the following outcome measures will be collected: subjective measure of symptom and functional limitation severity (Boston Carpal Tunnel Questionnaire); monofilament hand sensibility testing, grip and pinch strength; median nerve cross-sectional area measurement at the carpal tunnel inlet using ultrasound; and electrophysiologic function of the median nerve across the carpal tunnel (motor and sensory conduction velocities and amplitudes). At weekly intervals for the 1st month, each subject will also be contacted to report on their recovery (return to everyday activities including work) and any adverse effects/complications. The Boston Carpal Tunnel Questionnaire will also be completed at 1 month post TCTR. Assuming no serious complications are encountered from the initial 5 procedures, and upon approval from the supervising Data and Safety Monitoring Board, 15 additional carpal tunnels will undergo TCTR and the same outcome measures will be recorded. The outcome data will be analyzed using a repeated measures Analysis of Variance (Boston Carpal Tunnel Questionnaire; monofilament hand sensibility;grip and pinch strength; median nerve cross-sectional area; median nerve motor and sensory conduction velocities and amplitudes) and descriptive statistics (recovery duration and adverse effects/complications).

Being tested
Thread carpal tunnel release
Medical subject headings
Carpal Tunnel Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Thread carpal tunnel releaseProcedure or surgery

    Ultrasound-guided percutaneous minimally invasive thread carpal tunnel release using a looped thread technique

Study groups in NCT03476486
Study groupRoleWhat they receive
TreatmentExperimentalThe hand that was subject to thread carpal tunnel release surgery
Receives: Procedure: Thread carpal tunnel release
ControlNo interventionThe hand that was not treated

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Early recovery

    At weekly intervals for the 1st month ,each subject will also be contacted to report on their recovery (return to everyday activities including work) and any adverse effects/complications

    Measured: 1st month following the thread carpal tunnel release surgery

  2. Boston Carpal Tunnel Questionnaire

    subjective measure of symptom and functional limitation severity. Symptom and function subscale scores were summed (score range 2-10 with 2=asymptomatic and 10=severely symptomatic).

    Measured: a month prior to and at 3 and 6 months post procedure

  3. Hand sensation

    monofilament hand sensibility testing

    Measured: a month prior to and at 3 and 6 months post procedure

  4. grip and pinch strength

    Grip strength measured using a hand grip dynamometer; pinch strength measured with a pinch dynamometer

    Measured: a month prior to and at 3 and 6 months post procedure

  5. Median nerve cross-sectional area

    median nerve cross-sectional area measurement at the carpal tunnel inlet using ultrasound

    Measured: a month prior to and at 3 and 6 months post procedure

  6. Median nerve electrophysiologic function

    electrophysiologic function of the median nerve across the carpal tunnel (motor and sensory conduction velocities and amplitudes).

    Measured: a month prior to and at 3 and 6 months post procedure

  7. Subject satisfaction

    Global satisfaction score

    Measured: 3 and 6 months post thread carpal tunnel release

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Mar 2018
  2. Study start20 May 2016
  3. Primary completion20 Jan 2018
  4. Study completion20 Jan 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
controlled interventional clinical trial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03476486
Sponsor's protocol ID
Pro00060817
Status last verified
Mar 2018
First submitted
17 Mar 2018
Last updated
9 May 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Thread carpal tunnel release in people with Carpal Tunnel Syndrome, run by University of Alberta.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 May 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Early recovery (time frame: 1st month following the thread carpal tunnel release surgery). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in